'Pre clinical' presentation slideshows

Curriculum Development and Assessment in Medical Education Sultan Qaboos University

Curriculum Development and Assessment in Medical Education Sultan Qaboos University College of Medicine and Health Sciences 22 April 2009 Professor Nigel Bax Academic Unit of Medical Education School of Medicine and Biomedical Sciences University of Sheffield, UK

1.06k views • 75 slides

Development And Classification Of A Medicine

Development And Classification Of A Medicine. Niall Byrne Wednesday 30 th January 2012. Lecture plan. Development of a medicine: How can we categorise drugs? How do drugs cause their effects? Specific receptors: lock & key Non-specific effects Pharmacokinetics. Introduction.

893 views • 65 slides

Teaching Outside of the Box: Running a Pre-clinical Course

459 views • 33 slides

Microbicide Science and Research Update

Microbicide Science and Research Update. Jana Caylor Bowcut, MPH Research Associate Alliance for Microbicide Development. Global Campaign for Microbicides Pre-conference Microbicides 2004 28 March 2004. Presentation Outline . I. Biology of microbicides

433 views • 33 slides

Health Resource Center: Weekend Coordinator Orientation

Health Resource Center: Weekend Coordinator Orientation. Tuesday, 12 October, 2009. General Comments. Your role: you and another weekend coordinator will be in charge of running the clinic that weekend

392 views • 28 slides

Closing the Gaps in Philippine Drug Discovery & Development

Closing the Gaps in Philippine Drug Discovery & Development. Questions:. How can the Philippines respond to global and regional opportunities and threats afforded by the rapidly changing dynamics in the biopharmaceutical sector?

455 views • 26 slides

Statistical Work Experiences in a Major Pharmaceutical Company Qiming Liao, Ph.D Hui Zhi, Ph.D

Statistical Work Experiences in a Major Pharmaceutical Company Qiming Liao, Ph.D Hui Zhi, Ph.D GlaxoSmithKline Pharmaceuticals, R&D Nov 4, 2011. Presentation Overview. A Global Pharmaceutical Company (GSK as an example) Overview of the Drug Discovery & Development Process

391 views • 26 slides

INVESTOR PRESENTATION September 2005

396 views • 26 slides

Drug Development

Drug Development. Marilyn Lockyer, RN, BSc, CCRP Senior Clinical Research Coordinator King Faisal Heart Institute. What is a drug?. Any chemical compound Anything which produces a change in the body Defined by characteristics:

502 views • 24 slides

?????????

?????????. ??? ??? ?? Michael Hwang, D.V.M., Ph.D. ????????. ??? ??? ??. ??????????????? ( ?? ) ?? CR Rockville ????? ?? CR Rockville ???? ( ?????? ) ??? ????????? ?? ??????? ???????? ?? ??? ???? / ???????? ????? ????????? ??

788 views • 23 slides

Cross functional M&S

Cross functional M&S. Them. Us. The difference between them and us?. Cross functional Modelling and Simulation. $10500000000. $2000000000. C linical. Preclinical. Phase II. Phase I. Compound fulfilling criteria. Phase I. Compound fulfilling criteria. Phase I.

426 views • 22 slides

Confronting the major communicable diseases linked to poverty

Confronting the major communicable diseases linked to poverty. Health Directorate F3 unit: Poverty related Diseases Anne Degrand-Guillaud. Priority 1 Life sciences, genomics and biotechnology for health. Functional genomics (fundamental knowledge) Genomics and biotechnology for health

259 views • 17 slides

Adding Value: New Paradigms in Medical Education

Adding Value: New Paradigms in Medical Education. Isaac J. Kirstein, DO, FACOI Dean, Ohio University Heritage College of Osteopathic Medicine - Cleveland. A Call for Change. Inter-Dependence.

255 views • 12 slides

2 nd Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

2 nd Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD. Modular PMA Updates. Thinh Nguyen CDRH/ODE. Modular PMA Guidance. Revisions: Panel track supplements, i.e., those with pre-clinical data, may be submitted as modular PMA

318 views • 10 slides

PHARMACEUTICAL INNOVATIONS

PHARMACEUTICAL INNOVATIONS. Panel Discussion. MODERATOR Dr. Sergio Gurrieri PANELISTS Dr. Chunlin Chen Dr. Tina Huang Dr. Larry Wang Dr. Ming Guo Dr. Xifu Liu. TECH COAST ANGELS (TCA). Largest Angel Investors Organization in the US 300 Members in 5 Networks

353 views • 9 slides

New Faculty Orientation Curriculum Restructuring

New Faculty Orientation Curriculum Restructuring. Curriculum Restructuring Goals. Increase the amount of time for career exploration electives prior to the deadline for submitting residency applications

183 views • 9 slides

Strategic Drug Repositioning Exploit Opportunities and Accelerate R&D by Re-profiling Your Drugs

193 views • 8 slides

CTI Life Sciences Fund Introduction

147 views • 7 slides

Biotech Valuation Metrics

Clinical Candidate. Biotech Valuation Metrics. Product Opportunity. Pre-Clinical Candidate. Molecule Lead. Product Concept. V A L U E. Tool/ Technology. Performance. Compliance. D evelopability.

106 views • 2 slides

Biotech Valuation Metrics

Biotech Valuation Metrics. Clinical Candidate. Product Opportunity. Pre-Clinical Candidate. Product Concept. Molecule Lead. Tool/ Technology. Performance. Compliance. Richard C. Hsu | Partner | King & Spalding LLP Tel: 650.590.0743 | Cell: 650.504.2738 | rhsu@kslaw.com.

134 views • 1 slides